A case of non-small cell lung cancer with EGFR exon 20 insertion treated with osimertinib

被引：0
|
作者：
Morton-Gittens, Jamie [1 ]
Pipalia, Nisarg [2 ]
Liu, Hongxiang [3 ]
Thippu Jayaprakash, Kamalram [2 ]
机构：
[1] Queen Elizabeth Hosp, Dept Oncol, Kings Lynn, England
[2] Queen Elizabeth Hosp, Dept Oncol, Kings Lynn, Oncol Ctr,Addenbrookes Hosp, Cambridge, England
[3] Addenbrookes Hosp, Haematopathol & Oncol Diagnost Serv, Mol Malignancy Lab, Cambridge, England
来源：
LUNG CANCER | 2021年 / 156卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
177
引用
收藏
页码：S73 / S74
页数：2
相关论文
共 50 条
  • [1] Osimertinib treatment for patients with EGFR exon 20 insertion positive non-small cell lung cancer
    van Veggel, B.
    van der Wekken, A.
    Hashemi, S.
    Cornelissen, R.
    Monkhorst, K.
    Heideman, D.
    Radonic, T.
    Smit, E. F.
    Schuuring, E.
    De Langen, J.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [2] EGFR exon 20 insertion mutations in non-small cell lung cancer
    Wang, Fenfang
    Li, Chenghui
    Wu, Qihuan
    Lu, Hongyang
    [J]. TRANSLATIONAL CANCER RESEARCH, 2020, 9 (04) : 2982 - 2991
  • [3] EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer
    Wenfeng Fang
    Yihua Huang
    Shaodong Hong
    Zhonghan Zhang
    Minghui Wang
    Jiadi Gan
    Wenjing Wang
    Honglin Guo
    Kai Wang
    Li Zhang
    [J]. BMC Cancer, 19
  • [4] EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer
    Fang, Wenfeng
    Huang, Yihua
    Hong, Shaodong
    Zhang, Zhonghan
    Wang, Minghui
    Gan, Jiadi
    Wang, Wenjing
    Guo, Honglin
    Wang, Kai
    Zhang, Li
    [J]. BMC CANCER, 2019, 19 (1)
  • [5] Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer
    Simon Vyse
    Paul H. Huang
    [J]. Signal Transduction and Targeted Therapy, 4
  • [6] Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer
    Vyse, Simon
    Huang, Paul H.
    [J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2019, 4 (1)
  • [7] Osimertinib for Chinese advanced non-small cell lung cancer patients harboring diverse EGFR exon 20 insertion mutations
    Yang, Guang-Jian
    Li, Jun
    Xu, Hai-Yan
    Sun, Yang
    Liu, Liu
    Li, Hong-Shuai
    Yang, Lu
    Zhang, Yuan
    Li, Guo-Hui
    Wang, Yan
    [J]. LUNG CANCER, 2021, 152 : 39 - 48
  • [8] Osimertinib Treatment for Patients with EGFR exon 20 Insertion Positive Non-Small-Cell Lung Cancer
    Van Veggel, B.
    Van der Wekken, A.
    Hashemi, S.
    Cornelissen, R.
    Monkhorst, K.
    Heideman, D.
    Radonic, T.
    Schuuring, E.
    Smit, E.
    De Langen, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S815 - S815
  • [9] Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
    Wang, Mengzhao
    Yang, James Chih-Hsin
    Mitchell, Paul L.
    Fang, Jian
    Camidge, D. Ross
    Nian, Weiqi
    Chiu, Chao-Hua
    Zhou, Jianying
    Zhao, Yanqiu
    Su, Wu-Chou
    Yang, Tsung-Ying
    Zhu, Viola W.
    Millward, Michael
    Fan, Yun
    Huang, Wen-Tsung
    Cheng, Ying
    Jiang, Liyan
    Brungs, Daniel
    Bazhenova, Lyudmila
    Lee, Chee Khoon
    Gao, Bo
    Xu, Yan
    Hsu, Wei-Hsun
    Zheng, Li
    Janne, Pasi A.
    [J]. CANCER DISCOVERY, 2022, 12 (07) : 1676 - 1689
  • [10] Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer
    van Veggel, B.
    Santos, J. F. Vilacha Madeira R.
    Hashemi, S. M. S.
    Paats, M. S.
    Monkhorst, K.
    Heideman, D. A. M.
    Groves, M.
    Radonic, T.
    Smit, E. F.
    Schuuring, E.
    van der Wekken, A. J.
    de Langen, A. J.
    [J]. LUNG CANCER, 2020, 141 : 9 - 13
12345